Nobiletin (425 μM or 4 mg/ml) can inhibit the expression of MMP-2 and MMP-9 in glioma cells and reduce the motility, adhesion and invasion ability of glioma cells [49, 51]. Here, MMP2 is linked to central nervous system cancer.